APGE
Price
$28.79
Change
-$3.51 (-10.87%)
Updated
Apr 8 closing price
Capitalization
1.68B
40 days until earnings call
TRML
Price
$12.04
Change
-$0.18 (-1.47%)
Updated
Apr 9, 12:48 PM (EDT)
Capitalization
314.39M
Ad is loading...

APGE vs TRML

Header iconAPGE vs TRML Comparison
Open Charts APGE vs TRMLBanner chart's image
Apogee Therapeutics
Price$28.79
Change-$3.51 (-10.87%)
Volume$1.52M
Capitalization1.68B
Tourmaline Bio
Price$12.04
Change-$0.18 (-1.47%)
Volume$800
Capitalization314.39M
APGE vs TRML Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. TRML commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and TRML is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (APGE: $28.79 vs. TRML: $12.22)
Brand notoriety: APGE and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 211% vs. TRML: 97%
Market capitalization -- APGE: $1.68B vs. TRML: $314.39M
APGE [@Biotechnology] is valued at $1.68B. TRML’s [@Biotechnology] market capitalization is $314.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, both APGE and TRML are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 6 bearish.
  • TRML’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TRML is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -19.15% price change this week, while TRML (@Biotechnology) price change was -14.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.60%. For the same industry, the average monthly price growth was -16.25%, and the average quarterly price growth was -20.08%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

TRML is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (-10.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($1.68B) has a higher market cap than TRML($314M). APGE YTD gains are higher at: -36.446 vs. TRML (-39.744). TRML has higher annual earnings (EBITDA): -89.69M vs. APGE (-216.68M). APGE has more cash in the bank: 521M vs. TRML (258M). TRML has less debt than APGE: TRML (244K) vs APGE (11.8M). APGE (0) and TRML (0) have equivalent revenues.
APGETRMLAPGE / TRML
Capitalization1.68B314M534%
EBITDA-216.68M-89.69M242%
Gain YTD-36.446-39.74492%
P/E RatioN/AN/A-
Revenue00-
Total Cash521M258M202%
Total Debt11.8M244K4,836%
TECHNICAL ANALYSIS
Technical Analysis
APGETRML
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 24 days ago
84%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRGTX9.15N/A
N/A
VY® CBRE Global Real Estate S
FBTCX17.87N/A
N/A
Fidelity Advisor Biotechnology C
FKICX5.33N/A
N/A
Fidelity Small Cap Stock K6
MKVFX12.83N/A
N/A
MFS International Large Cap Value R3
WHGOX11.21N/A
N/A
Westwood Income Opportunity Ultra

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with ATXS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-10.87%
ATXS - APGE
49%
Loosely correlated
-16.67%
SYRE - APGE
49%
Loosely correlated
-4.76%
CRNX - APGE
48%
Loosely correlated
-3.11%
ELVN - APGE
47%
Loosely correlated
-11.47%
INZY - APGE
47%
Loosely correlated
-5.38%
More